The JOINSTAR booth was attended by existing and new potential business partners from all over the world. Overall there was a very positive response for the JOINSTAR products and offerings in【COVID-19 Rapid Antigen Test】, 【CoV-2 Influenza Antigen Rapid Test（3 in 1）】，【Monkeypox Antigen Rapid Test. However the main interest was on the Joinstar Rapid assay platforms 【Jet-iStar platforms (JS 800 and JS800 Plus)】which have an extensive menu of over 20 assays covering infection, cardiovascular, reproductive health, kidney disease, gastrointestinal function and blood coagulation. At the JOINSTAR booth over 75 short demonstrations were given showing the simplicity and user friendliness of the JOINSTAR POCT systems. There was considerable interest in the JOINSTAR sepsis markers including the novel and patented test for Heparin Binding Protein (HBP) as well as other routine markers such as Procalcitonin (PCT), Interleukin-6 (IL-6), C-reactive protein (CRP), and Serum Amyloid Protein A (SAA). Customers were impressed with the JOINSTAR JS800 Plus which can accommodate 6 different assays from a single patient sample.】
The testing projects cover six sectors: This is only quick diagnosis platform which can simultaneously detect
#JOINSTAR also showcased the【iMatrix 100 Automatic Analysis Flow Cytometry system】 This multi-plex
Patented Liquid chip encoding microsphere technology using digital signal processing technology allows for Multiple and rapid detection from single sample of 100 different analytes., Currently JOINSTAR offers detection of 12 different cytokines in a variety of formats to ensure maximum end-user options.
Post time: Nov-22-2022